For the treatment of patients with brain cancer, Cancer Research UK's Drug Development Office has opened up a new trial to investigate a new combination of drugs. The Phase I clinical trial will take place at The Beatson West of Scotland Cancer Centre in Glasgow, the Christie Hospital in Manchester, and the Royal Marsden Hospital and The Institute of Cancer Research in Sutton...

Scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have made a landmark discovery in the battle against the rapid spread of aggressive cancers associated with PRL-3 oncoprotein[1]...